A NEW CRO LANDSCAPE

Emblaveo marks the first and only fixed-dose intravenous monobactam/β-lactamase inhibitor combination antibiotic to be approved by the FDA for complicated intra-abdominal infections with limited treatment options.

Bill Grambley, CEO of AllazoHealth, delves into the potential of AI to revolutionize patient engagement and adherence.

The Phesi CEO discusses his company’s recent analysis of the most studied diseases in the world.

Dr. Lawrence B. Werlin, MD, FACOG of HRC Fertility (@md.lawrence.werlin on TikTok), discusses how to combat the spread of misinformation on social media, opportunities that social media presents, advancements in fertility technology, and more.

Market Data Analytics Buyer's Guide - Are you considering a medical claims data solution for healthcare business planning and strategy? Here’s how to make sense of the options.